AAAwad Alzahrani

Awad Alzahrani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Awad Alzahrani has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Automation Bias in AI-Assisted Simulated Radiotherapy Decision-Making Among Undergraduate Radiological Sciences Students: A Controlled Experimental Study

    by Nouf M. Alzahrani, Lojain Abdulaal, Awad Alzahrani, Meshal Alzahrani, Nasser M. Alzahrani, Reem M. Althubaiti, Abir Bouaoun

    Background: Artificial intelligence (AI) may support clinical decision-making but introduce automation bias when incorrect recommendations influence users. This study aimed to determine the occurrence of harmful automation bias among undergraduate radiological sciences students during AI-assisted radiotherapy decision-making and to examine the influence of time pressure. Methods: In a controlled experiment, 54 final-year undergraduate radiological sciences students with no prior clinical radiotherapy placement experience completed 20 simulated radiotherapy decision-making scenarios with 13 correct and seven deliberately incorrect AI recommendations (1080 trials). Initial and final responses, AI advice acceptance, confidence, perceived workload, and attitudes toward AI verification were assessed. Students were assigned to time-pressure (n = 26) or no-time-pressure (n = 28) conditions. Harmful automation bias was operationally defined as switching from an initially correct response to an incorrect response matching AI advice. Results: Harmful automation bias occurred in 20/220 eligible trials (9.1%), affecting 15/54 students (27.8%). Incorrect AI advice was followed in 137/378 trials (36.2%). Overall accuracy remained similar before and after AI exposure (75.65% vs. 74.91%; p = 0.289). Time pressure increased workload, but no statistically significant association with harmful automation bias was observed (OR = 0.78; p = 0.654). Lower post-decision confidence was associated with harmful automation bias (OR = 0.599; p = 0.028). No statistically significant difference in harmful automation bias was observed between participants who supported AI verification and those who did not. Conclusions: Harmful automation bias can occur despite stable overall accuracy, suggesting that greater emphasis on critical appraisal, active verification, and independent judgement may be valuable in radiotherapy education.

  • Open Access

    Associations of Pretreatment Hemoglobin, Body Mass Index, and Leukocyte Count with Acute and Late Toxicity During and After Radiotherapy for Rectal Cancer

    by Nouf M. Alzahrani, Alhanouf Alalyani, Raghad Almutairi, Hussam Hijazi, Farag Shuweihdi, Lojain Abdulaal, Bashair Alhummiany, Naglaa Elsayed, Awad Alzahrani, Meshal Alzahrani, et al.

    Background/Objectives: Radiotherapy is an important component of rectal cancer treatment, but treatment-related toxicity varies considerably between patients, suggesting that patient-related factors may influence susceptibility. Pretreatment hemoglobin, leukocyte count, and body mass index (BMI) are routinely available measures, yet their associations with acute and late toxicity during and after radiotherapy remain unclear. This study evaluated these associations in patients with rectal cancer. Methods: A retrospective analysis included 67 patients with histologically confirmed rectal cancer who underwent radiotherapy. Acute toxicity occurred during radiotherapy or within 3 months after treatment completion, and late toxicity occurred thereafter. Toxicity was graded using the Common Terminology Criteria for Adverse Events (CTCAE) and dichotomized as Grades 0–1 or Grade ≥ 2. Pretreatment hemoglobin, total leukocyte count, and BMI were analyzed as continuous variables. Logistic regression examined associations with acute and late toxicity, with sequential adjustment for age, sex, and radiotherapy course. Results: Grade ≥ 2 acute toxicity occurred in 17 patients (25.4%), and Grade ≥ 2 late toxicity in 27 (40.3%). Higher pretreatment leukocyte count was associated with greater odds of acute toxicity in the fully adjusted model (OR 1.70, 95% CI 1.13–2.58; p = 0.012). Higher pretreatment hemoglobin was associated with lower odds of late toxicity in the fully adjusted model (OR 0.57, 95% CI 0.40–0.81; p = 0.002). No clear association was observed between BMI and either acute or late toxicity. Conclusions: Pretreatment leukocyte count was associated with acute toxicity, while pretreatment hemoglobin was associated with late toxicity. These inexpensive, routinely available measures may represent candidate markers of toxicity, although their clinical utility requires validation in larger, independent studies.

  • Open Access

    Diagnostic Performance of Photon-Counting CT Angiography in Vascular Stenosis Assessment: A Systematic Review and Meta-Analysis

    by Nasser M. Alzahrani, Awad Alzahrani, Zyad M. Almutlaq, Ahmed Alghamdi, Yazeed Almukhlifi, Sultan A. Alotaibi, Jaber Alyami

    Objective: To evaluate the performance of photon-counting detector CT (PCD-CT) angiography for the detection and quantification of vascular stenosis. Methods: Web of Science, PubMed, and Cochrane databases were searched from January 1980 to December 2025 to identify studies assessing PCD-CT angiography for the detection and quantification of vascular stenosis, using invasive angiography as the reference standard. The risk of bias of the included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Diagnostic performance metrics, including sensitivity and specificity and quantification values, were extracted from the included studies and a formal narrative synthesis was performed. The meta-analysis included studies reporting true-positive, false-positive, true-negative, and false-negative data. A meta-analysis was conducted only when a minimum of two eligible studies assessed diagnostic performance within the given vascular territory. Statistical analyses were performed using R software (v4.5.0), applying a random-effects model for the meta-analysis. Results: Of 415 identified studies, 20 were included in the systematic review, comprising a total of 9165 participants, with the majority (17/20, 85%) focusing on coronary artery stenosis. In the meta-analysis of three studies, ultra-high-resolution (UHR) PCD-CT demonstrated excellent diagnostic performance for detecting coronary stenosis for patients with ≥50%, having a pooled sensitivity of 96.1% (95% confidence level (CI): 89.3–99.6), specificity of 87.5% (95% CI: 78.2–93.3), positive predictive value (PPV) of 91.9% (95% CI: 70.3–98.2), and negative predictive value (NPV) of 94.8% (95% CI: 86.0–98.6). Compared with conventional energy-integrating detector CT (EID-CT), PCD-CT consistently showed superior diagnostic performance, particularly in the specificity and PPV. In terms of stenosis quantification, PCD-CT showed closer agreement with reference standards than EID-CT, leading to the reclassification of coronary stenosis severity in up to 49% of patients. Evidence for non-coronary vascular territories, including intracranial and peripheral arteries remains limited but suggests promising diagnostic performance. For lower-limb arterial stenosis, the reported sensitivity was 77.4–91%, and specificity was 72.1–91%. For intracranial in-stent stenosis, PCD-CT demonstrated a sensitivity of 100% and a specificity of 89%. Conclusions: PCD-CT angiography provides high diagnostic performance and improved stenosis quantification for coronary artery stenosis. UHR PCD-CT has excellent diagnostic performance for detecting coronary stenosis and consistently outperforms conventional EID-CT, especially in the specificity and positive predictive value.


  • Open Access

    Preliminary Evaluation of the Effect of Body Weight on Contrast Enhancement in Coronary CT Angiography: A Fixed Iodine-Dose Protocol

    by Fahad Alraddadi, Hasan Almalki, Rana Saklou, Faris Jawad, Zyad M. Almutlaq, Awad Alzahrani, Meshal Alzahrani, Ghada Alturkstani, Waleed Alharbi, Wed Shaibah, et al.

    Objective: To assess the effectiveness of a fixed contrast injection protocol—75 mL of contrast followed by 40 mL saline at 5 mL/s with an injection duration of 23 s—in achieving diagnostic enhancement in coronary CT angiography (CCTA) using 64-slice detector CT scanner. Materials and Methods: 456 consecutive patients with suspected coronary disease who underwent CCTA on a 64-slice detector CT scanner between January 2023 and December 2024 and were retrospectively enrolled. Each patient received 75 mL of contrast medium followed by 40 mL of saline at a flow rate of 5 mL/s, with a total injection duration of 23 s. Two radiologists, blinded to patient information, independently measured the contrast enhancement (HU) values in the coronary segments, ascending and descending aorta, and left ventricle. Attenuation levels ≥250 HU were considered diagnostic. Patients were grouped by body weight into two categories: Group 1 (≤75 kg) and Group 2 (>75 kg). The independent t-test and Mann–Whitney U test were used to compare HU values in each vessel between the two groups, while the Chi-square test was applied to compare enhancement success rates (HU ≥ 250) between the groups per vessel. Results: A total of 281 patients (mean age: 51.88 years ± 11.15 [SD]; 167 male, 114 female), were included. Statistically significant differences in the HU enhancement measurements were found between groups (p < 0.001–0.007). However, all segments showed mean and median HU values above 250 HU. Enhancement success rates were significantly higher in Group 1 (p = 0.005–0.04), except in the ascending aorta, descending aorta, left main coronary artery, middle right coronary, distal right coronary artery, and middle left circumflex artery, where the rates were statistically comparable between the groups (p = 0.054–0.61). Conclusions: A fixed contrast protocol (75 mL of contrast medium followed by 40 mL of saline at a 5 mL/s flow rate with a total injection duration of 23 s) appears to be feasible for achieving diagnostic contrast enhancement in CCTA using a 64-slice multidetector CT scanner. This protocol may offer a simplified alternative to individualized, weight-based contrast dosing strategies.